EQ insider buying and SEC filings, explained
Equillium, Inc. · CIK 1746466
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- DE
- Fiscal year end
- Dec 31
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$723K
Planned sales (10b5-1)
$1.7M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jun 5, 2026 | Planned (10b5-1) | Christine Zedelmayer (President / COO) sold 14,584 shares at about $2.93 ($43K), marked as a 10b5-1 plan trade. Holdings down 19% to 62,586 shares. | SEC filing Filed Jun 5, 2026 |
| Jun 4–5, 2026 | Sale | Stephen Connelly (President / COO) sold 230,975 shares between Jun 4 and Jun 5 at about $3.13 ($723K). Holdings down 23% to 762,025 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 5, 2026 |
| May 28, 2026 | Planned (10b5-1) | Penny Tom (Principal Accounting Officer) sold 65,000 shares at about $2.95 ($192K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed May 29, 2026 |
| May 27–28, 2026 | Planned (10b5-1) | Christine Zedelmayer (President / COO) sold 95,833 shares between May 27 and May 28 at about $2.79 ($267K), marked as a 10b5-1 plan trade. Holdings down 60% to 62,586 shares. | SEC filing Filed May 29, 2026 |
| Mar 13, 2026 | Planned (10b5-1) | Christine Zedelmayer (President / COO) sold 120,312 shares at about $2.50 ($301K), marked as a 10b5-1 plan trade. Holdings down 66% to 62,586 shares. | SEC filing Filed Mar 16, 2026 |
| Mar 9, 2026 | Planned (10b5-1) | Christine Zedelmayer (President / COO) sold 181,219 shares at about $2.00 ($362K), marked as a 10b5-1 plan trade. Holdings down 74% to 62,586 shares. | SEC filing Filed Mar 11, 2026 |
| Feb 19, 2026 | Planned (10b5-1) Amended filing | Christine Zedelmayer (President / COO) sold 185,937 shares at about $1.76 ($328K), marked as a 10b5-1 plan trade. Holdings down 67% to 91,444 shares. This amends a filing from Feb 23. | SEC filing Filed Mar 11, 2026 |
| Jan 8, 2026 | Planned (10b5-1) | Penny Tom (Principal Accounting Officer) sold 6,533 shares at $1.29 ($8K), marked as a 10b5-1 plan trade. Holdings down 100% to 0 shares. | SEC filing Filed Jan 9, 2026 |
| Dec 23, 2025 | Planned (10b5-1) | Christine Zedelmayer (President / COO) sold 100,000 shares at $1.50 ($150K), marked as a 10b5-1 plan trade. Holdings down 52% to 91,444 shares. | SEC filing Filed Dec 23, 2025 |
| Dec 12–15, 2025 | Planned (10b5-1) | Christine Zedelmayer (President / COO) sold 35,704 shares between Dec 12, 2025 and Dec 15, 2025 at about $1.33 ($47K), marked as a 10b5-1 plan trade. Holdings down 28% to 91,444 shares. | SEC filing Filed Dec 15, 2025 |
| Nov 25, 2025 | Planned (10b5-1) | Christine Zedelmayer (President / COO) sold 8,098 shares at about $0.9504 ($8K), marked as a 10b5-1 plan trade. Holdings down 6% to 127,148 shares. | SEC filing Filed Nov 25, 2025 |
16 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow EQ in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.